- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 205/06 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Patent holdings for IPC class C07D 205/06
Total number of patents in this class: 56
10-year publication summary
|
4
|
7
|
5
|
5
|
1
|
3
|
5
|
5
|
6
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The General Hospital Corporation | 4875 |
5 |
| The Broad Institute, Inc. | 1986 |
5 |
| Howard Hughes Medical Institute | 232 |
5 |
| Sanofi | 4319 |
5 |
| Massachusetts Institute of Technology | 10282 |
4 |
| Canopy Growth Corporation | 212 |
3 |
| Exelixis, Inc. | 394 |
3 |
| BioMarin Pharmaceutical Inc. | 398 |
2 |
| Kannalife Sciences, Inc. | 7 |
2 |
| Vividion Therapeutics, Inc. | 44 |
2 |
| Bausch + Lomb Ireland Limited | 737 |
2 |
| Capstan Therapeutics, Inc. | 32 |
2 |
| The Regents of the University of California | 20815 |
1 |
| Janssen Pharmaceutica N.V. | 3160 |
1 |
| Centre National de La Recherche Scientifique | 11059 |
1 |
| Board of Regents, The University of Texas System | 6141 |
1 |
| Aerie Pharmaceuticals, Inc. | 38 |
1 |
| Cellixbio Private Limited | 142 |
1 |
| City University of Hong Kong | 960 |
1 |
| Incyte Corporation | 1066 |
1 |
| Other owners | 8 |